Abstract:OBJECTIVE—The key pancreatic transcription factor pancreatic duodenal homeobox-1 (Pdx1), known to control development and maintenance of pancreatic β-cells, possesses a protein transduction domain (PTD) that facilitates its entry into cells. We therefore sought to evaluate the capacity of in vivo–administered recombinant Pdx1 (rPdx1) to ameliorate hyperglycemia in mice with streptozotocin-induced diabetes. RESEARCH DESIGN AND METHODS—Cell entry and transcriptional regulatory properties of rPdx1 protein and its PTD-deletion mutant rPdx1Δ protein, as well as a PTD–green fluorescent protein, were evaluated in vitro. After intraperitoneal rPdx1 injection into mice with streptozotocin-induced diabetes, we assessed its action on blood glucose levels, insulin content, intraperitoneal glucose tolerance test (IPGTT), Pdx1 distribution, pancreatic gene expression, islet cell proliferation, and organ histology. RESULTS—Restoration of euglycemia in Pdx1-treated diabetic mice was evident by improved IPGTT and glucose-stimulated insulin release. Insulin, glucagon, and Ki67 immunostaining revealed increased islet cell number and proliferation in pancreata of rPdx1-treated mice. Real-time PCR of pancreas and liver demonstrated upregulation of INS and PDX1 genes and other genes relevant to pancreas regeneration. While the time course of β-cell gene expression and serum/tissue insulin levels indicated that both liver- and pancreas-derived insulin contributed to restoration of normoglycemia, near-total pancreatectomy resulted in hyperglycemia, suggesting that β-cell regeneration played the primary role in rPdx1-induced glucose homeostasis. CONCLUSIONS—rPdx1 treatment of mice with streptozotocin-induced diabetes promotes β-cell regeneration and liver cell reprogramming, leading to restoration of normoglycemia. This novel PTD-based protein therapy offers a promising way to treat patients with diabetes while avoiding potential side effects associated with the use of viral vectors.

A small-molecule inducer of PDX1 expression identified by high-throughput screening

Characterization of Pancreatic Transcription Factor Pdx-1 Binding Sites Using Promoter Microarray and Serial Analysis of Chromatin Occupancy*

In Vivo and in Vitro Studies of a Functional Peroxisome Proliferator-activated Receptor Γ Response Element in the Mouse Pdx-1 Promoter

Human Expandable Pancreatic Progenitor–derived Β Cells Ameliorate Diabetes

Andrographolide Promotes Pancreatic Duct Cells Differentiation into Insulin-Producing Cells by Targeting PDX-1.

Small Molecules Facilitate the Reprogramming of Mouse Fibroblasts into Pancreatic Lineages

Tectorigenin Enhances PDX1 Expression and Protects Pancreatic Β-Cells by Activating ERK and Reducing ER Stress

Reversal of Streptozotocin-Induced Diabetes in Mice by Cellular Transduction with Recombinant Pancreatic Transcription Factor Pancreatic Duodenal Homeobox-1

Peroxisome proliferator-activated receptor-α regulates the expression of pancreatic/duodenal homeobox-1 in rat insulinoma (INS-1) cells and ameliorates glucose-induced insulin secretion impaired by palmitate

Insulin Stimulates Pancreatic-Duodenal Homoeobox Factor-1 (pdx1) Dna-Binding Activity and Insulin Promoter Activity in Pancreatic Beta Cells

Pdxl and its role in activating Ngn3 and Pax6 to induce differentiation of iPSCs into islet β cells

Differentiation of Mouse Embryonic Stem Cells toward Functional Pancreatic β-Cell Surrogates through Epigenetic Regulation of Pdx1 by Nitric Oxide

In Vitropancreas Duodenal Homeobox-1 Enhances the Differentiation of Pancreatic Ductal Epithelial Cells into Insulin-Producing Cells

Comprehensive Single Cell Mrna Profiling Reveals a Detailed Roadmap for Pancreatic Endocrinogenesis.

AMPK Enhances the Expression of Pancreatic Duodenal Homeobox-1 Via PPARα, but Not PPARγ, in Rat Insulinoma Cell Line INS-1

A Novel Synthetic Human Insulin Super Promoter for Targeting PDX-1-expressing Pancreatic Cancer

Pancreatic and Duodenal Homeobox Gene 1 (pdx1) Down-Regulates Hepatic Transcription Factor 1 Alpha (hnf1α) Expression During Reprogramming of Human Hepatic Cells into Insulin-Producing Cells.

Harnessing Endogenous Transcription Factors Directly by Small Molecules for Chemically Induced Pluripotency Inception.

The Study of Regulatory Effects of Pdx-1, MafA and NeuroD1 on the Activity of Porcine Insulin Promoter and the Expression of Human Islet Amyloid Polypeptide

Effect of PDX-1 on the Expression of Pancreas Islet Development-Related Genes.

Developing a Sensitive Reporter System for Monitoring of Pancreatic and Duodenal Homeobox Gene 1 (pdx1) and Neurogenin 3 (ngn3) – Mediated Transdifferentiation from Human Hepatic Cells into Insulin-Producing Beta-Like Cells